Profil
Jonas Christopher Frisén was the founder of Newron Sweden AB, a company founded in 1998 where he held the title of Director.
Dr. Frisén is also the founder of Spatial Transcriptomics AB. Currently, he is a Professor at Karolinska Institutet, a position he has held since 2012.
Postes actifs de Jonas Christopher Frisén
| Sociétés | Poste | Début |
|---|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Spatial Transcriptomics AB
Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Provides cells analysis in morphological context to genetic activity | Fondateur | - |
Anciens postes connus de Jonas Christopher Frisén
| Sociétés | Poste | Fin |
|---|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Health Technology |
Spatial Transcriptomics AB
Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Provides cells analysis in morphological context to genetic activity | Commercial Services |
















